Younger lung cancer patients more likely to harbor targetable mutations, study finds
Younger adults with non-small cell lung cancer are substantially more likely than older patients to carry genetic alterations that can ...
Younger adults with non-small cell lung cancer are substantially more likely than older patients to carry genetic alterations that can ...
In a breakthrough that could redefine treatment standards for a rare subset of lung cancer patients, researchers from The University ...
In a groundbreaking advance poised to reshape the therapeutic landscape of lung cancer treatment, researchers have identified a novel small ...
Emerging research from a leading group of scientists has shed new light on the complex interplay between systemic inflammation and ...
In a remarkable new study published in BMC Cancer, researchers have uncovered how the drug chidamide—a histone deacetylase inhibitor—exerts multifaceted ...
In a groundbreaking advancement for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), a novel investigational agent, zidesamtinib, has ...
In a groundbreaking study that pushes the frontier of cancer genomics, researchers have unveiled the hidden world of non-coding genetic ...
In the relentless battle against non-small cell lung cancer (NSCLC), a new beacon of hope emerges through the strategic combination ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine